The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of SER-109, an investigational microbiome therapeutic for recurrent clostridioides difficile infection: Data from ECOSPOR III, a phase 3 randomized trial.
 
Alla Paskovaty
Employment - Seres Therapeutics
Stock and Other Ownership Interests - Seres Therapeutics
 
Charles S. Berenson
No Relationships to Disclose
 
Thomas J. Louie
Consulting or Advisory Role - Crestone; MGB Biopharma; Seres Therapeutics; Vedanta Biosciences
Research Funding - Crestone (Inst); Finch Therapeutics (Inst); MGB Biopharma (Inst); Seres Therapeutics (Inst); Summit (Inst); Vedanta Biosciences (Inst)
Expert Testimony - Ferring
 
Elaine Wang
Employment - Seres Therapeutics
Stock and Other Ownership Interests - Seres Therapeutics
 
David A. Lombardi
Consulting or Advisory Role - Seres Therapeutics
 
Lisa von Moltke
Employment - Seres Therapeutics
Leadership - Seres Therapeutics
Stock and Other Ownership Interests - Seres Therapeutics